Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

RAPP

Rapport Therapeutics, Inc.

CIK 0002012593 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$42.05
↑ 0.06 (0.14%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$2.01B
P/E Ratio
-16.15
EPS
-2.86
Dividend Yield
Not covered
52W Position
95%
Beta
1.50

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
4.26
P/S
Not covered
EV/Revenue
Not covered
ROE
-22.8%
Valuation data covers 8,500/9,463 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 95%
$11.91$43.76

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$111.48M
Total Assets
$512.43M
Free Cash Flow
-$88.09M

Recent news